Ignite Creation Date:
2025-12-25 @ 2:43 AM
Ignite Modification Date:
2026-02-27 @ 5:41 AM
Study NCT ID:
NCT02835833
Status:
COMPLETED
Last Update Posted:
2018-07-10
First Post:
2016-07-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Nintedanib Plus Bevacizumab in Advanced Solid Tumors
Sponsor:
University of Alabama at Birmingham
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-06-09
Start Date Type:
ACTUAL
Primary Completion Date:
2018-04-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-06-14
Completion Date Type:
ACTUAL
First Submit Date:
2016-07-07
First Submit QC Date:
None
Study First Post Date:
2016-07-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-07-09
Last Update Post Date:
2018-07-10
Last Update Post Date Type:
ACTUAL